13F HOLDINGS REPORT
CVS HEALTH Corp
Quarter ended Q2 2024 · Filed August 9, 2024 · Accession 0000947871-24-000669
Total Value
$216.8M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S P 500 ETF TRUST | SPY | 287,891 | $156.7M | 72.25% |
| 2 | VANGUARD WHITEHALL FDS | 921946406 | 252,032 | $29.9M | 13.78% |
| 3 | ISHARES CORE HIGH DIVIDEND ETF | 46429B663 | 273,110 | $29.7M | 13.69% |
| 4 | PRUDENTIAL FINANCIAL INC | PUKPF | 2,683 | $314,421 | 0.14% |
| 5 | HEALTH CATALYST INC | HCAT | 32,273 | $206,221 | 0.10% |
| 6 | LUMIRADX LTD | G5709L117 | 5,352,106 | $72,789 | 0.03% |